Online Purchasing Account You are logged on as Guest. LoginRegister a New AccountShopping cart (Empty)
United States 

Hypericin (native)

PKC inhibitor
ALX-350-030-M001 1 mg 89.00 USD
ALX-350-030-M005 5 mg 348.00 USD
ALX-350-030-M010 10 mg 615.00 USD
Do you need bulk/larger quantities?
Replaces Prod. #: BML-EI226

A potent and selective inhibitor of protein kinase C (IC50=3.4µM). Anti-viral and anti-retroviral actitity. Displays antineoplastic and antitumor actitities. Most activities require light activation. Induces apoptosis in neuroblastoma cells at 1µM or above (IC50=0.1µM at 29 mW/cm2 (tungsten light)). Inhibitition of other kinases (e.g. EGFR-PTK, CKII and MAP kinase). Bright red fluorescence emissino and photostability. Antidepressant.

Product Details

Source:Isolated from Hypericum perforatum.
MI:14: 4863
Purity:≥98% (HPLC)
Appearance:Dark brown to black-red powder.
Solubility:Soluble in DMSO (25mg/ml), 100% ethanol, methanol, acetone, ethylmethylketone, pyridine or other organic solvents and bases.
Shipping:Ambient Temperature
Long Term Storage:+4°C
Use/Stability:High purity hypericin tautomerizes to 1,6-dioxo tautomer in the presence of water contained in solvents.
Handling:Protect from light and oxygen.
Regulatory Status:RUO - Research Use Only
Please mouse over

Product Literature References

Cellular mechanisms and prospective applications of hypericin in photodynamic therapy: T. Kiesslich, et al.; Curr. Med. Chem. 13, 2189 (2006), (Review), Abstract;
Hypericin--the facts about a controversial agent: A. Kubin, et al.; Curr. Pharm. Des. 11, 233 (2005), (Review), Abstract;
Hypericin--a new antiviral and antitumor photosensitizer: mechanism of action and interaction with biological macromolecules: P. Miskovsky; Curr. Drug Targets 3, 55 (2002), (Review), Abstract;
Apoptotic and anti-apoptotic signaling pathways induced by photodynamic therapy with hypericin: P. Agostinis, et al.; Adv. Enzyme Regul. 40, 157 (2000), Abstract;
Hypericin induces both differentiation and apoptosis in human promyelocytic leukemia HL-60 cells: K.T. Lee, et al.; Biol. Pharm. Bull. 22, 1271 (1999), Abstract;
Over-expression of Bcl-2 does not protect cells from hypericin photo- induced mitochondrial membrane depolarization, but delays subsequent events in the apoptotic pathway: R. Chaloupka, et al.; FEBS Lett. 462, 295 (1999), Abstract;
The activation of the c-Jun N-terminal kinase and p38 mitogen-activated protein kinase signaling pathways protects HeLa cells from apoptosis following photodynamic therapy with hypericin: Z. Assefa, et al.; J. Biol. Chem. 274, 8788 (1999), Abstract; Full Text
Hypericin-induced photosensitization of HeLa cells leads to apoptosis or necrosis. Involvement of cytochrome c and procaspase-3 activation in the mechanism of apoptosis: A. Vantieghem, et al.; FEBS Lett. 440, 19 (1998), Abstract;
Growth inhibition and apoptosis in human neuroblastoma SK-N-SH cells induced by hypericin, a potent inhibitor of protein kinase C: W. Zhang, et al.; Cancer Lett. 96, 31 (1995), Abstract;
Novel therapeutic and diagnostic applications of hypocrellins and hypericins: Z. Diwu; Photochem. Photobiol. 61, 529 (1995), Abstract;
Photosensitized inhibition of growth factor-regulated protein kinases by hypericin: P. Agostinis, et al.; Biochem. Pharmacol. 49, 1615 (1995), Abstract;
The chemical and biological properties of hypericin--a compound with a broad spectrum of biological activities: G. Lavie et al.; Med. Res. Rev. 15, 111 (1995), Abstract;
Evaluation of the antiviral activity of anthraquinones, anthrones and anthraquinone derivatives against human cytomegalovirus: D.L. Barnard, et al.; Antiviral Res. 17, 63 (1992), Abstract;
Photosensitization is required for inactivation of equine infectious anemia virus by hypericin: S. Carpenter & G.a. Kraus ; Photochem. Photobiol. 53, 169 (1991), Abstract;
Hypericin and pseudohypericin specifically inhibit protein kinase C: possible relation to their antiretroviral activity: I. Takahashi, et al.; BBRC 165, 1207 (1989), Abstract;
Therapeutic agents with dramatic antiretroviral activity and little toxicity at effective doses: aromatic polycyclic diones hypericin and pseudohypericin: D. Meruelo, et al.; PNAS 85, 5230 (1988), Abstract;

Related Literature

Integrated solutions for screening Wnt regulators
Integrated solutions for screening Wnt regulators
Download as PDF

Download as PDF

All new literature pieces